← Back to catalogue

Ihc

FDA UDI

Class I (US FDA UDI)

by Slmp, LLC

Identity

Trade Name
IHC FDA UDI
Generic Name
Tumour-associated glycoprotein-72 (TAG72) IVD, antibody FDA UDI
Device Name
TAG-72/CA 72-4, Clone B72.3, 10ml FDA UDI
Model / Reference
(BTO) TAG-72/CA 72-4 (B72.3) Antibody (10ml) FDA UDI
Description
TAG-72/CA 72-4, Clone B72.3, 10ml FDA UDI

Identifiers

Catalog Number
MM137-10 FDA UDI
Primary DI / UDI-DI
00810170550676 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Tumour-associated glycoprotein-72 (TAG72) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Tumour-associated glycoprotein-72 (TAG72) IVD, antibody

Ihc by Slmp, LLC — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Tumour-associated glycoprotein-72 (TAG72) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Slmp, LLC

Sources (1)

  • FDA UDI 8df70212-3925-49c6-b46a-9a0b34d82e8d 34 fields · synced May 30, 2026